THE EFFECT OF ASA SCORE ON MORTALITY RATE IN PATIENTS WITH INTRAPARENCHYMAL HEMORRHAGE

Abstract

Objective We aimed to evaluate the effect of hematoma volumes and preoperative ASA scores on mortality of the patients we operated on due to intraparenchymal hematoma. Materials and Methods This study was conducted by retrospectively scanning the files of 34 patients operated on for intraparenchymal hematoma in our hospital’s neurosurgery clinic between February 2015 and February 2020. The preoperative glasgow coma score, hematoma volume, antiaggregant use, presence of hypertension, localization of bleeding and whether it was opened to the ventricle and ASA scores of the patients were collected to evaluate. Results Of the 34 patients included in the study, 20 were male, and 14 were female. Preoperative mean hematoma volumes of the patients were 120 cm3 (min: 41 – max: 278 cm3). In the follow-up of the patients, 28 of them were dead, and our mortality rate was 82%. A significant correlation was found between hematoma volumes and mortality (P<0.05). 11 of the patients were evaluated as ASA 2, 4 as ASA 3, 17 as ASA 4, and 2 patients as ASA 5. No significant correlation was found between the patients' ASA score and mortality (P>0.05). Conclusion Glasgow coma score and ASA score are important factors determining mortality. The glasgow coma score and ASA score should be evaluated together. Even if the glasgow coma score score is low, mortality decreases in patients without comorbid diseases.

Keywords

• Intraparenchymal Hemorrhage
• Hematoma volume
• Glasgow coma score
• ASA
• Mortality

İNTRAPARENKİMAL KANAMALI HASTALARDA ASA SKORUNUN MORTALİTE ORANINA ETKİSİ

Abstract

Amaç İntraparenkimal hematom nedeniyle opere ettiğimiz hastaların hematom hacimleri ve preoperatif ASA skorlarının mortaliteye etkisini değerlendirmeyi amaçladık. Gereç ve Yöntem Çalışmamız hastanemiz Beyin ve Sinir Cerrahisi kliniğinde Şubat 2015 - Şubat 2020 tarihleri arasında intraparenkimal hematom nedeniyle opere edilen 34 hastanın dosyaları geriye dönük olarak taranması ile yürütüldü. Hastaların preoperatif glaskow koma skoru, hematom hacmi, antiagregan kullanımı, hipertansiyon varlığı, kanamanın lokalizasyonu ve ventriküle açılıp açılmadığı ve ASA skorları değerlendirilmek için toplandı. Bulgular Çalışmaya dahil edilen 34 hastanın 20’i erkek 14’ü kadın hastaydı. Hastaların geliş anındaki ortalama hematom hacimleri 120cm3 ( min:41 – max: 278 cm3)’dü. Hastaların takiplerinde 28 tanesi ex olmuş olup mortalite oranımız %82’dir. Hematom hacimleri ile mortalite arasında anlamlı bir ilişki saptanmıştır (P<0.05). Hastaların 11’i ASA 2, 4’ ü ASA 3, 17’si ASA 4 ve 2 hasta ASA 5 olarak değerlendirilmiştir. Hastaların ASA skoru ile mortalitesi değerlendirildiğinde anlamlı bir ilişki saptanmamıştır( P>0.05). Sonuç Glaskow koma skoru ve ASA skoru mortaliteyi belirleyen önemli faktörlerdir. Glaskow koma skoru ve ASA skoru birlikte değerlendirilmelidir. Glaskow koma skoru düşük bile olsa komorbid hastalıkları olmayan hastalarda mortalite azalmaktadır.

Keywords

• İntraparenkimal hematom
• Hematom hacmi
• Glaskow koma skoru
• ASA
• Mortalite

References

1. 1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. The Lancet Neurology. 2009;8(4):355-69.
2. 2. Hong K-S, Bang OY, Kang D-W, Yu K-H, Bae H-J, Lee JS, et al. Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke. Journal of stroke. 2013;15(1):2.
3. 3. Krishnamurthi RV, Moran AE, Forouzanfar MH, Bennett DA, Mensah GA, Lawes CM, et al. The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study. Global heart. 2014;9(1):101-6.
4. 4. Broderick JP, Adams Jr HP, Barsan W, Feinberg W, Feldmann E, Grotta J, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999;30(4):905-15.
5. 5. Flaherty M, Haverbusch M, Sekar P, Kissela B, Kleindorfer D, Moomaw C, et al. Long-term mortality after intracerebral hemorrhage. Neurology. 2006;66(8):1182-6.
6. 6. Abouleish AE, Leib ML, Cohen NH. ASA provides examples to each ASA physical status class. ASA Monitor. 2015;79(6):38-49.
7. 7. Bakır A, Yılmaz ER, Sarılar C, Tuna H, Çağlar Ş. İntraserebral Hematomlar. Türk Nöroşir Derg. 2006;16(1):42-44.
8. 8. Evcili G, Ak H, Boro UT, Yaycioglu S. Evaluation of the Effects of Aspirin and Warfarin Use on the Volume of Intracranial Non-Traumatic Hemorrhage and Mortality Rate. Journal of Neurology Research. 2012;2(3):99-103.

9. 9. Broderick JP. Advances in the treatment of hemorrhagic stroke: a possible new treatment. Cleveland Clinic journal of medicine. 2005;72(4):341-4.
10. 10. Van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. The Lancet Neurology. 2010;9(2):167-76.
11. 11. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Validation and comparison of models predicting survival following intracerebral hemorrhage. Critical care medicine. 1995;23(5):950-4.
12. 12. Davis S, Broderick J, Hennerici M, Brun N, Diringer M, Mayer S, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66(8):1175-81.
13. 13. Kanaya H. Current status of surgical therapy of hypertensive cerebral hemorrhage in Japan. Nihon rinsho Japanese journal of clinical medicine. 1982;40(12):2775-82.
14. 14. Dolgun H, Hanalioğlu Ş, Gürses L, Gülce G, Başar İ, GÜNAYDIN A, et al. Spontan İntraserebral Hematomların Cerrahi Tedavisi. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi. (3):439-46.
15. 15. An SJ, Kim TJ, Yoon B-W. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. Journal of stroke. 2017;19(1):3.
16. 16. Auer LM, Deinsberger W, Niederkorn K, Gell G, Kleinert R, Schneider G, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. Journal of neurosurgery. 1989;70(4):530-5.
17. 17. Hemphill III JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32(4):891-7.
18. 18. Wang C-Y, Chen Y-C, Chien T-H, Chang H-Y, Chen Y-H, Chien C-Y, et al. Impact of comorbidities on the prognoses of trauma patients: Analysis of a hospital-based trauma registry database. PloS one. 2018;13(3):e0194749.
19. 19. Rantner B, Eckstein H-H, Ringleb P, Woelfle KD, Bruijnen H, Schmidauer C, et al. American Society of Anesthesiology and Rankin as predictive parameters for the outcome of carotid endarterectomy within 28 days after an ischemic stroke. Journal of Stroke and Cerebrovascular Diseases. 2006;15(3):114-20.
20. 20. Pateder DB, Gonzales RA, Kebaish KM, Cohen DB, Chang J-Y, Kostuik JP. Short-term mortality and its association with independent risk factors in adult spinal deformity surgery. Spine. 2008;33(11):1224-8.